Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 7, 2026
NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line System...
October 8, 2026
Medspoke
Medspoke
The Lancet Oncology
Published October 7, 2026
00:00
--:--
Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive,...
October 8, 2026
Share
Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial.
https://www.medspoke.co/channel_journal?id=686&tap_id=15242
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Nature Reviews Clinical Oncology
Published October 7, 2026
Exercise therapy in cancer prevention and treatment.
October 8, 2026
Why are you reporting this TALK?
